Telomere and Telomerase as Targets for Cancer Therapy

被引：44
作者：
Tian, Xiaoping [1 ]
Chen, Bo [1 ]
Liu, Xiaochuan [1 ]
机构：
[1] Zhejiang Sci Tech Univ, Bioengn Inst, Life Sci Coll, Hangzhou 310018, Peoples R China
来源：
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY | 2010年 / 160卷 / 05期
关键词：
Telomere; Telomerase; Telomere dysfunction; Telomerase RNA; Cancer therapy; HTERT MESSENGER-RNA; REVERSE-TRANSCRIPTASE EXPRESSION; TUMOR-ASSOCIATED ANTIGEN; CYTOTOXIC T-LYMPHOCYTES; SINGLE-STRAND OVERHANG; GROWTH IN-VITRO; SUICIDE GENE; STEM-CELLS; CELLULAR SENESCENCE; INHIBITION;
D O I：
10.1007/s12010-009-8633-9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Telomere maintenance and telomerase reactivation is essential for the transformation of most human cancer cells. Telomere shortening to the threshold length, mutations of the telomere-associated proteins, and/or telomerase RNA lead to telomeric dysfunction and therefore genomic instability. Telomerase up-regulation in 85% of human cancer cells has become a hallmark of cancers, hence a promising target for anticancer therapy. In this review, we discuss the mechanism of cancer due to telomere dysfunction and the resulting biological effects, the control of telomerase activity, and the new developments in cancer therapies targeting telomere and telomerase.
引用
收藏
页码：1460 / 1472
页数：13
相关论文
共 97 条
  • [61] THROMBIN-BINDING DNA APTAMER FORMS A UNIMOLECULAR QUADRUPLEX STRUCTURE IN SOLUTION
    MACAYA, RF
    SCHULTZE, P
    SMITH, FW
    ROE, JA
    FEIGON, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3745 - 3749
  • [62] Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway
    Maida, Y
    Kyo, S
    Kanaya, T
    Wang, Z
    Yatabe, N
    Tanaka, M
    Nakamura, M
    Ohmichi, M
    Gotoh, N
    Murakami, S
    Inoue, M
    [J]. ONCOGENE, 2002, 21 (26) : 4071 - 4079
  • [63] MAKINO S, 1959, ACTA UNION INT CONTR, V15, P196
  • [64] Functional characterization of novel telomerase RNA (TEM) mutations in patients with diverse clinical and pathological presentations
    Marrone, Anna
    Sokhal, Priya
    Walne, Amanda
    Beswick, Richard
    Kirwan, Michael
    Killick, Sally
    Williams, Mike
    Marsh, Judith
    Vulliamy, Tom
    Dokal, Inderjeet
    [J]. HAEMATOLOGICA, 2007, 92 (08) : 1013 - 1020
  • [65] RUNAWAY TELOMERE ELONGATION CAUSED BY TELOMERASE RNA GENE-MUTATIONS
    MCEACHERN, MJ
    BLACKBURN, EH
    [J]. NATURE, 1995, 376 (6539) : 403 - 409
  • [66] Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
    Minev, B
    Hipp, J
    Firat, H
    Schmidt, JD
    Langlade-Demoyen, P
    Zanetti, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (09) : 4796 - 4801
  • [67] Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation
    Muramatsu, Yukiko
    Tahara, Hidetoshi
    Ono, Taeko
    Tsuruo, Takashi
    Seimiya, Hiroyuki
    [J]. EXPERIMENTAL CELL RESEARCH, 2008, 314 (05) : 1115 - 1124
  • [68] Telomerase inhibition, telomerase shortening, and senescence of cancer cells by tea catechins
    Naasani, I
    Seimiya, H
    Tsuruo, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) : 391 - 396
  • [69] Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
    Nair, SK
    Heiser, A
    Boczkowski, D
    Majumdar, A
    Naoe, M
    Lebkowski, JS
    Vieweg, J
    Gilboa, E
    [J]. NATURE MEDICINE, 2000, 6 (09) : 1011 - 1017
  • [70] Using natural product inhibitors to validate Hsp90 as a molecular target in cancer
    Neckers, Len
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (11) : 1163 - 1171
12345678910